Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zabrina L Brumme

Showing results (31-40 of 210) with videos related to

Pageof 21
Sort By:
Plos One|September 23, 2017
Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, CanadaGenevieve Rocheleau, Conrado Franco-Villalobos, Natalia Oliveira, et al.
Ebiomedicine|October 20, 2019
Detection of HIV transmission hotspots in British Columbia, Canada: A novel framework for the prioritization and allocation of treatment and prevention resourcesAngela McLaughlin, Paul Sereda, Natalia Oliveira, et al.
Journal of Virology|July 13, 2018
Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C InfectionDoty B A Ojwach, Daniel MacMillan, Tarylee Reddy, et al.
Bioinformatics (Oxford, England)|March 3, 2022
HAMdetector: a Bayesian regression model that integrates information to detect HLA-associated mutationsDaniel Habermann, Hadi Kharimzadeh, Andreas Walker, et al.
The Journal of Infectious Diseases|October 20, 2005
Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3Adrienne R Toulson, Richard Harrigan, Katherine Heath, et al.
Virology|March 31, 2019
Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypesLisa Naidoo, Zinhle Mzobe, Steven W Jin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2007
A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptaseCelia K S Chui, Zabrina L Brumme, Chanson J Brumme, et al.
AIDS (London, England)|October 17, 2018
Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youthZabrina L Brumme, Hanwei Sudderuddin, Carrie Ziemniak, et al.
Pathogens (Basel, Switzerland)|September 27, 2019
Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort StudyBirkneh Tilahun Tadesse, Adugna Chala, Jackson Mukonzo, et al.
Journal of Virology|September 11, 2015
Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef FunctionAniqa Shahid, Alex Olvera, Gursev Anmole, et al.
Pageof 21

Showing results (31-40 of 210) with videos related to

Sort By:
Pageof 21
Plos One|September 23, 2017
Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, CanadaGenevieve Rocheleau, Conrado Franco-Villalobos, Natalia Oliveira, et al.
Ebiomedicine|October 20, 2019
Detection of HIV transmission hotspots in British Columbia, Canada: A novel framework for the prioritization and allocation of treatment and prevention resourcesAngela McLaughlin, Paul Sereda, Natalia Oliveira, et al.
Journal of Virology|July 13, 2018
Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C InfectionDoty B A Ojwach, Daniel MacMillan, Tarylee Reddy, et al.
Bioinformatics (Oxford, England)|March 3, 2022
HAMdetector: a Bayesian regression model that integrates information to detect HLA-associated mutationsDaniel Habermann, Hadi Kharimzadeh, Andreas Walker, et al.
The Journal of Infectious Diseases|October 20, 2005
Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3Adrienne R Toulson, Richard Harrigan, Katherine Heath, et al.
Virology|March 31, 2019
Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypesLisa Naidoo, Zinhle Mzobe, Steven W Jin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2007
A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptaseCelia K S Chui, Zabrina L Brumme, Chanson J Brumme, et al.
AIDS (London, England)|October 17, 2018
Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youthZabrina L Brumme, Hanwei Sudderuddin, Carrie Ziemniak, et al.
Pathogens (Basel, Switzerland)|September 27, 2019
Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort StudyBirkneh Tilahun Tadesse, Adugna Chala, Jackson Mukonzo, et al.
Journal of Virology|September 11, 2015
Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef FunctionAniqa Shahid, Alex Olvera, Gursev Anmole, et al.
Pageof 21